The FDA has been busy with stem cell-related activities this spring. Busier than publicly apparent. Very busy, indeed! Earlier, I reported that they issued a warning letter to cosmetician to the stars, Dr. LookGood, as well as one to another doc selling stem cell therapies. Now it seems apparent that even more is going on … FDA visits both ICMS and reportedly Celltex: the scoop! Read More »